Last quarter (Q4 2023), Ginkgo Bioworks Holdings's total revenue was $34.76M, a decrease of -64.64% from the same quarter last year. In Q4, Ginkgo Bioworks Holdings's net income was $-211.69M. See Ginkgo Bioworks Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20
Total Revenue	$ 251.46M	$ 251.46M	$ 477.71M	$ 313.84M	$ 76.66M
Cost of Revenue	$ 46.52M	$ 46.52M	$ -183.57M	$ -109.67M	$ 15.61M
Gross Profit	$ 204.93M	$ 204.93M	$ 273.49M	$ 184.15M	$ 61.05M
Operating Expense	$ 1.12B	$ 1.12B	$ -2.69B	$ -2.14B	$ 198.07M
Operating Income	$ -864.41M	$ -864.41M	$ -2.20B	$ -1.83B	$ -137.03M
Net Non Operating Interest Income Expense	$ 57.12M	$ 57.12M	$ 20.16M	$ -1.54M	$ 197.00K
Other Income Expense	$ 191.01M	$ 191.01M	$ -59.76M	$ 30.21M	$ 12.00M
Pretax Income	$ -892.94M	$ -892.94M	$ -2.12B	$ -1.84B	$ -124.83M
Tax Provision	$ -71.00K	$ -71.00K	$ -15.03M	$ -1.48M	$ 1.89M
Earnings From Equity Interest Net Of Tax	$ -2.63M	$ -2.63M	$ -43.76M	$ -77.28M	-
Net Income Common Stockholders	$ -892.87M	$ -892.87M	$ -2.10B	$ -1.83B	$ -126.61M
Basic EPS	$ -0.41	$ -0.46	$ -1.25	$ -1.35	$ -0.09
Diluted EPS	$ -0.41	$ -0.46	$ -1.25	$ -1.39	$ -0.09
Basic Average Shares	$ 7.78B	$ 1.94B	$ 1.68B	$ 1.36B	$ 1.49B
Diluted Average Shares	$ 7.78B	$ 1.94B	$ 1.68B	$ 1.36B	$ 1.49B
Dividend Per Share	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-
Total Expenses	$ 690.08M	$ 1.16B	$ -2.87B	$ -2.25B	$ 213.68M
Net Income From Continuing And Discontinued Operation	$ -892.87M	$ -892.87M	$ -2.10B	$ -1.83B	$ -126.61M
Normalized Income	$ -343.59M	-	-	-	$ -129.93M
Interest Expense	-	-	-	-	$ 2.38M
EBIT	$ -724.96M	$ -892.93M	$ -2.13B	$ -1.86B	$ -122.45M
EBITDA	$ -680.57M	$ -793.06M	$ -2.08B	$ -1.83B	$ -108.58M

Currency in USD

Ginkgo Bioworks Holdings Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing